WO2004032801A1 - Intraluminal medical device having improved visibility - Google Patents
Intraluminal medical device having improved visibility Download PDFInfo
- Publication number
- WO2004032801A1 WO2004032801A1 PCT/US2003/028220 US0328220W WO2004032801A1 WO 2004032801 A1 WO2004032801 A1 WO 2004032801A1 US 0328220 W US0328220 W US 0328220W WO 2004032801 A1 WO2004032801 A1 WO 2004032801A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- end portions
- elongated
- structural material
- radiopaque
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/92—Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0096—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
- A61F2250/0098—Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
Definitions
- Stents are generally tubular shaped devices that function to hold open a segment of a blood vessel or other anatomical lumen and are useful in the treatment of atherosclerotic stenoses in blood vessels. Stents are particularly suitable for use in supporting and holding back a dissected arterial lining that can occlude the fluid passageway therethrough .
- Stents are available in a variety of configurations, including self- expanding and mechanical expanding varieties, but regardless of the configuration, are typically delivered to the site of the atherosclerotic stenosis through the use of a catheter delivery device.
- various means are employed for identifying the position of the stent within a blood vessel.
- the stents themselves are typically formed of a metal, metal alloy or polymeric material which is not readily visible using known techniques for viewing the stent such as fluoroscopy or MRI, such characteristics must be imparted to the stent structure.
- One method is to impart radiopacity to the stent structure such as by attachment of markers to the stent structure, or by making the entire stent from a radiopaque material, so that, through the use of fluoroscopy, the position of the stent within a blood vessel can be identified. Once the stent with its radiopaque markers has been implanted, identification of the stent position during subsequent checkups of the treated segment is easily accomplished because the markers remain visible under fluoroscopy. Another method is to provide stent materials which are visible using MRI.
- Stents are most commonly formed of materials which have little radiopacity such as stainless steel or shape memory metal alloys such as NITINOL® which is a nickel-titanium shape memory alloy, for example. For one, making the entire stent out of a radiopaque material can be quite costly. Another disadvantage is that the stent may fluoresce too brightly which may actually make it more difficult for the physician to accurately position the stent, as well as to make follow up checks on the functioning of the stent more difficult.
- Radiopaque markers there have been several methods employed for attaching radiopaque markers to a stent.
- One method has been to coat the deformable portions of the stent with radiopaque material. This can require a relatively thick coating in order to provide enough radiopaque material to be visible using fluoroscopy, and can also alter the mechanical performance of the stent.
- radiopaque material Another method has been to insert radiopaque material into a hollow stent wire.
- Other methods of attaching radiopaque markers have been employed such as that described in US 6334871 in which radiopaque markers described therein as rivets are inserted into openings in the stent.
- Fig. 1 is a partial view of a stent according to the present invention having elongated end portions.
- Fig. 2 is a partial view of an alternative embodiment of a stent according to the present invention having elongated and enlarged end portions.
- Fig. 3 is a partial view of an alternative embodiment of a stent according to the present invention having end portions designed for accepting fiducial markers for enhancing visibility.
- Fig. 4 is a partial view of an alternative embodiment of a stent according to the present invention in which the end portions include a void for inserting fiducial markers.
- Fig. 5 is a partial view of an alternative embodiment of a stent similar to that shown in Fig. 4 wherein the end portions have alternative voids for inserting fiducial markers.
- Fig. 6 is a flat pattern of a stent according to the present invention wherein the stent exhibits two elongated end portions interspersed with a non-elongated end portion.
- Fig. 6a is an exploded partial view of the same stent as shown in Fig. 6.
- Fig. 7 is a flat pattern of a stent according to the present invention wherein the stent exhibits two non-elongated end portions separated by one elongated end portion.
- Fig. 7a is an exploded partial view of the same stent as shown in Fig. 7.
- Fig. 8 is a schematic of a spiral embodiment of the stent.
- the present invention relates to intraluminal medical devices, including stents and stent grafts having fiducial markers to enhance visibility of the device in the vasculature of a patient both during the delivery and placement of the device, and for future observation of the device during follow up visits.
- the stents of the present invention are tubular structures formed of a se ⁇ entine structure that typically includes at least one se ⁇ entine band and desirably a plurality of se ⁇ entine bands which are interconnected by connecting members between adjacent se ⁇ entine bands.
- the se ⁇ entine bands may be in the form of circumferential bands or bands which spiral about the longitudinal axis of the stent.
- the se ⁇ entine bands are formed of a plurality of struts, adjacent ones of which are connected by alternating end portions. The end portions have inner turns and outer turns. Some of the end portions in the stent circular band pattern are elongated and are configured so as to provide enhanced visibility of that portion of the stent structure.
- the elongated end portions do not extend substantially beyond the non-elongated end portions, however.
- the outer turns of the elongated portions do not have to align longitudinally with the outer turns of the non-elongated portions, and the inner turns of the elongated portions do not have to align longitudinally with the inner turns of the non-elongated portions.
- the enhanced visibility is provided by having elongated end portions with increased mass.
- the elongated end portions may also be enlarged in addition to being elongated.
- the elongated end portions with higher mass are preferentially configured such that the elongated end portions do not extend substantially longitudinally beyond the other non-elongated end portions of the band.
- the end portion includes an extension which inco ⁇ orates a fiducial marker.
- the overall length of the extension and the end portion does not extend substantially beyond the length of the other end portions which are neither elongated, nor have any extensions.
- the outer turns of the end portions having the extension do not have to longitudinally align with the outer turns of the other end portions, and the inner turns of the end portions having the extensions do not have to longitudinally align with the inner turns of the other end portions.
- the elongated end portions may be adapted to receive a fiducial marker such as a plug, rivet, wire winding, band, filling, coating or the like.
- proximal-most outer turns 20a and 20b are substantially longitudinally aligned with one another and distal-most outer turns 20a and 20b are substantially longitudinally aligned with one another.
- the stents of the present invention are tubular structures formed of a se ⁇ entine structure that typically includes at least one and desirably a plurality of se ⁇ entine bands.
- the se ⁇ entine bands may be circumferential bands or may spiral about the longitudinal axis of the stent.
- Each se ⁇ entine band is formed of a plurality of struts which are interconnected by end portions, each end portion having an inner turn and an outer turn. Where a plurality of se ⁇ entine bands are present, the se ⁇ entine bands are also interconnected by connecting elements.
- Some of the end portions of the stent structures of the present invention are adapted to provide enhanced visibility using imaging techniques such as fluoroscopy or magnetic resonance imaging (MRI) by providing elongated or extended end portions of sufficient area or mass which can serve as fiducial markers themselves or in conjunction with at least a second material provided in the region of the elongated or extended end portion.
- imaging techniques such as fluoroscopy or magnetic resonance imaging (MRI)
- Fig. 1 is a partial view of a stent 10 formed of a plurality of circumferential bands 12 which are interconnected by connecting elements 22.
- the connecting elements 22 shown in this and the following figures are shown as straight connecting elements.
- Fig. 1 Shown in Fig. 1 is a single circumferential band 12 but the connecting elements 22 to the next circumferential band are visible.
- Band 12 is formed of a plurality of struts interconnected by end portions 16a, 16b, each end portion having an inner turn 18a, 18b and an outer turn 20a, 20b.
- Some of the end portions 16b of each circumferential band are designed to exhibit enhanced visibility, desirably by providing enhanced radiopacity when using fluoroscopic techniques, or by providing different MRI properties when using MRI.
- the end portions 16b have an elongated structure for providing increased mass and enhanced radiopacity.
- not all of the turns of the end portions need be substantially longitudinally aligned with one another.
- the elongated end portions 16b have outer turns 20b, which do not extend substantially beyond the outer turns 20a of any of the other non-elongated end portions 16a.
- the inner turns, 18b, of the elongated end portions 16b are not substantially longitudinally aligned with the inner turns 18a of the non-elongated end portions 16a.
- Fig. 2 shows generally at 10, a partial view of another embodiment of a stent structure according to the present invention.
- the overall structure is substantially similar to that of Fig. 1, but, the end portions 16b, are not only elongated, but are further enlarged as well. Again, none of the outer turns 20b, of the elongated, enlarged end portions 16b, extend longitudinally substantially beyond the end portions of 16a.
- the inner turns 18b of the elongated and enlarged end portions 16b are not substantially longitudinally aligned with the inner turns 18a of the non-elongated end portions 16a.
- Fig. 3 is a partial view of yet another embodiment of a stent according to the present invention.
- the end portions 16b have an extension 17 for attaching a fiducial marker such as a wire winding, marker band, plating, coating and the like, for example.
- the inner turns 18b of the end portions 16b having the extensions 17 do not longitudinally align with the inner turns 18a of the end portions 16a which have no extensions.
- the outer turns 20b of end portions 16b which have extensions 17, are not substantially longitudinally aligned with the outer turns 20a of the other end portions 16a which do not have any extensions.
- the extensions 17 of the end portions 16b do not, however, extend substantially beyond the length of the end portions 16a.
- Figs. 4 and 5 are illustrative of another embodiment of the stent structure according to the present invention in which the elongated end portions are adapted for receiving some sort of fiducial marker such as a plug, rivet, filling, plating, coating and so forth.
- Fig. 4 illustrates an embodiment of the present invention in which a substantial portion of the elongated end portions 16b is adapted with a fitting 19 for accepting a visibility enhancing marker 21.
- the circumferential band as shown has a plurality of non-elongated end portions 16a and a plurality of elongated end portions 16b. Again, the length of the elongated end portions 16b does not extend substantially beyond the length of the non-elongated end portions 16a.
- the outer turns 20b of the elongated end portions 16b are substantially longitudinally aligned with the outer turns 20a of the non-elongated end portions 16a in this embodiment, but this is not a requirement.
- the inner turns 18b of the elongated end portions 16b are not substantially longitudinally aligned with the inner turns 18a of the non-elongated end portions 16a.
- Fig. 5 illustrates an embodiment of the present invention which is substantially similar to that shown in Fig. 4, with the exception that the fitting 17 for accepting the fiducial marker 19, is smaller, in relation to the elongated end portion 16b.
- Fig. 6 shows a flat pattern of a stent 10 according to the present invention formed of a plurality of bands 12 interconnected by connecting elements 22. The actual stent is tubular.
- Band 12 is formed of a plurality of struts interconnected by end portions 16a, 16b, each end portion having an inner turn 18a, 18b and an outer turn 20a, 20b.
- the end portions 16b of each circumferential band are designed to exhibit enhanced visibility, desirably by providing enhanced radiopacity when using fluoroscopic techniques, or by providing different MRI properties when using MRI.
- the end portions 16b have an elongated structure for providing increased mass and enhanced radiopacity.
- Fig. 6a is an exploded view of a portion of the stent 10 shown in Fig. 6 illustrating the elongated end portions 16b. Variations may be made in the structure shown in Figs. 6 and 6a such as having more than two adjacent elongated end portions 16b, for example. Furthermore, while connecting elements 22 shown in Figs. 6 and 6a are straight, other variations may be employed such as curved, bent, linear, curvilinear, and so forth.
- Fig. 7 shows a flat pattern of an alternative embodiment of the stent 10 according to the present invention formed of a plurality of interconnecting bands 12 interconnected by connecting elements 22. The actual stent is tubular.
- Band 12 is formed of a plurality of struts interconnected by end portions 16a, 16b, each end portion having an inner turn 18a, 18b and an outer turn 20a, 20b.
- Some of the end portions 16b of each circumferential band are designed to exhibit enhanced visibility, desirably by providing enhanced radiopacity when using fluoroscopic techniques, or by providing different MRI properties when using MRI.
- the end portions 16b have an elongated structure for providing increased mass and enhanced radiopacity.
- FIG. 7a is an exploded view of a portion of the stent 10 shown in Fig. 7 illustrating the elongated end portions 16b. Variations may be made in the structure shown in Figs. 7 and 7a such as having more than two adjacent non- elongated end portions 16a, for example. Furthermore, while connecting elements 22 shown in Figs. 6 and 6a are straight, other variations may be employed such as curved, bent, linear, curvilinear, and so forth.
- a stent may comprise a single band such as that shown in figures l-7a or a plurality of such bands.
- the inventive stents may also be provided in other configurations as well.
- any of the inventive stents disclosed herein may also be provided in spiral embodiments in which the se ⁇ entine bands or cellular structures spiral about the longitudinal axis of the stent.
- An example of such a configuration is shown schematically in a flat pattern in Fig. 8.
- Some of the peaks 16b at the end of the stent are provided with elongated end portions to serve as fiducial markers and some of the peaks 16a do not have elongated end portions.
- any of the inventive stents disclosed herein may also be provided in a 'jelly roll' configuration.
- the flat pattern of Fig. 7 may be rolled into a tube without securing the longitudinal edges to one another.
- Such a stent would be deployed by unrolling of the stent and expansion of the cells or bands which extend about the longitudinal axis of the stent.
- An example of such a stent is disclosed in WOO 132099.
- the stents according to the present invention are formed of at least one base material hereinafter referred to as the structural material. Any suitable material known in the art for forming such intraluminal medical devices may be employed including both metallic materials and polymeric materials, although metallic materials are preferred.
- suitable metallic materials include, but are not limited to stainless steel, and shape memory alloys.
- suitable metallic materials include, but are not limited to, NITINOL® which is a nickel-titanium alloy, cobalt-chromium alloys such as
- ELGILOY® platinum-tungsten alloys, and so forth.
- Other alloys which may be employed in making formation of the stent structure include, but are not limited to, cobalt chromium alloys, other alloys of titanium cobalt-chromium molybdenum alloys, and so forth.
- the fiducial markers enhance visibility of the stent in conjunction with an imaging modality such as, for example, MRI and fluoroscopy.
- an imaging modality such as, for example, MRI and fluoroscopy.
- One way to provide regions of altered MR contrast in an intraluminal medical device is to employ polymeric materials containing a paramagnetic ion.
- Ferromagnetic materials such as iron, nickel, cobalt and alloys of these materials may also enhance the visualization of the desired regions of the stent.
- Paramagnetic materials including gadolinium and alloys and salts thereof may also be used to alter the imaging characteristics of the stent.
- polychelating and amphiphilic polymers include those having poly-L-lysine (PLL) as the main chain and chelating moieties such as diethylene traimine pentaacetic acid or DTPA as side groups.
- PLL poly-L-lysine
- radiopaque marker materials which may be employed in the formation of the radiopaque marker include, but are not limited to, the noble metals including ruthenium (Ru), rhodium (Rd), palladium (Pd), osmium (Os), iridium (Ir), platinum (Pt), silver (Ag), and gold (Au), tantalum (Ta), rhenium (Re), and so forth, molybdenum, iodine and its salts or compounds, barium and its salts or compounds, bismuth and its salts or compounds, tungsten, and so forth. Polymeric materials which inco ⁇ orate radiopaque materials such as barium, may also be employed to form radiopaque marker materials.
- the noble metals including ruthenium (Ru), rhodium (Rd), palladium (Pd), osmium (Os), iridium (Ir), platinum (Pt), silver (Ag), and gold (Au), tantalum (Ta),
- the invention is also directed to other embodiments having any other possible combination of the dependent features claimed below.
- the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the invention such that the invention should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims.
- any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims).
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60333481T DE60333481D1 (en) | 2002-10-09 | 2003-08-27 | INTRALUMINAL PROSTHESIS WITH IMPROVED VISIBILITY |
AT03752146T ATE474531T1 (en) | 2002-10-09 | 2003-08-27 | INTRALUMINAL PROSTHESIS WITH IMPROVED VISIBILITY |
EP03752146A EP1572028B1 (en) | 2002-10-09 | 2003-08-27 | Intraluminal medical device having improved visibility |
AU2003270453A AU2003270453A1 (en) | 2002-10-09 | 2003-08-27 | Intraluminal medical device having improved visibility |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/269,112 | 2002-10-09 | ||
US10/269,112 US7331986B2 (en) | 2002-10-09 | 2002-10-09 | Intraluminal medical device having improved visibility |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004032801A1 true WO2004032801A1 (en) | 2004-04-22 |
Family
ID=32068705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/028220 WO2004032801A1 (en) | 2002-10-09 | 2003-08-27 | Intraluminal medical device having improved visibility |
Country Status (6)
Country | Link |
---|---|
US (2) | US7331986B2 (en) |
EP (1) | EP1572028B1 (en) |
AT (1) | ATE474531T1 (en) |
AU (1) | AU2003270453A1 (en) |
DE (1) | DE60333481D1 (en) |
WO (1) | WO2004032801A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1452151A2 (en) * | 2003-02-25 | 2004-09-01 | Cordis Corporation | Stent with nested fingers for enhaced vessel coverage |
WO2005030286A1 (en) * | 2003-09-24 | 2005-04-07 | Boston Scientific Limited | Medical device with markers for magnetic resonance visibility |
EP1570807A2 (en) * | 2003-10-29 | 2005-09-07 | Medtronic Vascular, Inc. | Intralumenal stent device for use in body lumens of various diameters |
US7918884B2 (en) | 2003-02-25 | 2011-04-05 | Cordis Corporation | Stent for treatment of bifurcated lesions |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250058B1 (en) | 2000-03-24 | 2007-07-31 | Abbott Cardiovascular Systems Inc. | Radiopaque intraluminal stent |
GB0020491D0 (en) | 2000-08-18 | 2000-10-11 | Angiomed Ag | Stent with attached element and method of making such a stent |
US8252034B2 (en) * | 2001-01-05 | 2012-08-28 | Chambers Jeffrey W | Method of positioning a stent using rods |
US8197535B2 (en) * | 2001-06-19 | 2012-06-12 | Cordis Corporation | Low profile improved radiopacity intraluminal medical device |
AU2002325298A1 (en) | 2001-07-06 | 2003-01-21 | Angiomed Gmbh And Co. Medizintechnik Kg | Delivery system having a rapid pusher assembly for self-expanding stent, and stent exchange configuration |
GB0123633D0 (en) | 2001-10-02 | 2001-11-21 | Angiomed Ag | Stent delivery system |
WO2003092549A2 (en) | 2002-05-06 | 2003-11-13 | Abbott Laboratories | Endoprosthesis for controlled contraction and expansion |
WO2003094798A1 (en) | 2002-05-08 | 2003-11-20 | Abbott Laboratories | Endoprosthesis having foot extensions |
US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
US9561123B2 (en) | 2002-08-30 | 2017-02-07 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
US7223283B2 (en) * | 2002-10-09 | 2007-05-29 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
GB0327306D0 (en) * | 2003-11-24 | 2003-12-24 | Angiomed Gmbh & Co | Catheter device |
MXPA05007537A (en) | 2003-01-15 | 2005-09-21 | Angiomed Ag | Trans-luminal surgical device. |
BRPI0409894B1 (en) * | 2003-04-30 | 2016-04-12 | Nipro Corp | expandable flexible stent |
US7625398B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US7625401B2 (en) * | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20050171428A1 (en) * | 2003-07-21 | 2005-08-04 | Gabor Fichtinger | Registration of ultrasound to fluoroscopy for real time optimization of radiation implant procedures |
US20050060025A1 (en) * | 2003-09-12 | 2005-03-17 | Mackiewicz David A. | Radiopaque markers for medical devices |
US20050182474A1 (en) * | 2004-02-13 | 2005-08-18 | Medtronic Vascular, Inc. | Coated stent having protruding crowns and elongated struts |
JP5007888B2 (en) * | 2004-05-05 | 2012-08-22 | インヴァテック エス.ピー.エイ. | Lumen prosthesis |
US20050278017A1 (en) * | 2004-06-09 | 2005-12-15 | Scimed Life Systems, Inc. | Overlapped stents for scaffolding, flexibility and MRI compatibility |
US20050283226A1 (en) * | 2004-06-18 | 2005-12-22 | Scimed Life Systems, Inc. | Medical devices |
JP4844394B2 (en) * | 2004-06-25 | 2011-12-28 | 日本ゼオン株式会社 | Stent |
US20060074480A1 (en) | 2004-09-01 | 2006-04-06 | Pst, Llc | Stent and method for manufacturing the stent |
US9468704B2 (en) | 2004-09-07 | 2016-10-18 | Biotronik Vi Patent Ag | Implant made of a biodegradable magnesium alloy |
EP2169090B3 (en) | 2008-09-30 | 2014-06-25 | Biotronik VI Patent AG | Implant made of a biodegradable magnesium alloy |
US7488444B2 (en) * | 2005-03-03 | 2009-02-10 | Icon Medical Corp. | Metal alloys for medical devices |
US7540995B2 (en) * | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
US7452501B2 (en) * | 2005-03-03 | 2008-11-18 | Icon Medical Corp. | Metal alloy for a stent |
US20060276910A1 (en) * | 2005-06-01 | 2006-12-07 | Jan Weber | Endoprostheses |
EP1895938B1 (en) * | 2005-06-30 | 2019-02-20 | Abbott Laboratories | Endoprosthesis having foot extensions |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
US20070173925A1 (en) * | 2006-01-25 | 2007-07-26 | Cornova, Inc. | Flexible expandable stent |
CA2948428C (en) * | 2006-02-14 | 2020-06-30 | Angiomed Gmbh & Co. Medizintechnik Kg | Highly flexible stent and method of manufacture |
GB0609841D0 (en) * | 2006-05-17 | 2006-06-28 | Angiomed Ag | Bend-capable tubular prosthesis |
GB0609911D0 (en) | 2006-05-18 | 2006-06-28 | Angiomed Ag | Bend-capable stent prosthesis |
US8752268B2 (en) | 2006-05-26 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Method of making stents with radiopaque markers |
US20070288084A1 (en) * | 2006-06-09 | 2007-12-13 | Medlogics Device Corporation | Implantable Stent with Degradable Portions |
GB0613670D0 (en) * | 2006-07-10 | 2006-08-16 | Angiomed Ag | Tubular metal prosthesis and method of making it |
WO2008008291A2 (en) * | 2006-07-13 | 2008-01-17 | Icon Medical Corp. | Stent |
DE102006038232A1 (en) * | 2006-08-07 | 2008-02-14 | Biotronik Vi Patent Ag | Endoprosthesis and method for producing such |
GB0616579D0 (en) * | 2006-08-21 | 2006-09-27 | Angiomed Ag | Self-expanding stent |
GB0616729D0 (en) * | 2006-08-23 | 2006-10-04 | Angiomed Ag | Method of welding a component to a shape memory alloy workpiece |
US20080215132A1 (en) * | 2006-08-28 | 2008-09-04 | Cornova, Inc. | Implantable devices having textured surfaces and methods of forming the same |
GB0616999D0 (en) * | 2006-08-29 | 2006-10-04 | Angiomed Ag | Annular mesh |
EP2063824B1 (en) * | 2006-09-07 | 2020-10-28 | Angiomed GmbH & Co. Medizintechnik KG | Helical implant having different ends |
US8414637B2 (en) * | 2006-09-08 | 2013-04-09 | Boston Scientific Scimed, Inc. | Stent |
US8211163B2 (en) * | 2006-09-13 | 2012-07-03 | Boston Scientific Scimed, Inc. | Hybrid symmetrical stent designs |
GB0622465D0 (en) * | 2006-11-10 | 2006-12-20 | Angiomed Ag | Stent |
GB0624419D0 (en) * | 2006-12-06 | 2007-01-17 | Angiomed Ag | Stenting ring with marker |
GB0703379D0 (en) * | 2007-02-21 | 2007-03-28 | Angiomed Ag | Stent with radiopaque marker |
US8512392B2 (en) * | 2007-03-09 | 2013-08-20 | Boston Scientific Scimed, Inc. | Stent design with struts of various angles and stiffness |
US8545548B2 (en) | 2007-03-30 | 2013-10-01 | DePuy Synthes Products, LLC | Radiopaque markers for implantable stents and methods for manufacturing the same |
GB0706499D0 (en) * | 2007-04-03 | 2007-05-09 | Angiomed Ag | Bendable stent |
US7810223B2 (en) * | 2007-05-16 | 2010-10-12 | Boston Scientific Scimed, Inc. | Method of attaching radiopaque markers to intraluminal medical devices, and devices formed using the same |
US8211162B2 (en) | 2007-05-25 | 2012-07-03 | Boston Scientific Scimed, Inc. | Connector node for durable stent |
DE102007030753A1 (en) * | 2007-07-02 | 2009-01-08 | Acandis Gmbh & Co. Kg | stent |
GB0717481D0 (en) | 2007-09-07 | 2007-10-17 | Angiomed Ag | Self-expansible stent with radiopaque markers |
US9180030B2 (en) | 2007-12-26 | 2015-11-10 | Cook Medical Technologies Llc | Low profile non-symmetrical stent |
US9226813B2 (en) | 2007-12-26 | 2016-01-05 | Cook Medical Technologies Llc | Low profile non-symmetrical stent |
GB2476451A (en) | 2009-11-19 | 2011-06-29 | Cook William Europ | Stent Graft |
US8574284B2 (en) * | 2007-12-26 | 2013-11-05 | Cook Medical Technologies Llc | Low profile non-symmetrical bare alignment stents with graft |
US9592100B2 (en) * | 2007-12-31 | 2017-03-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for encoding catheters with markers for identifying with imaging systems |
US8128678B2 (en) * | 2008-09-02 | 2012-03-06 | Cook Medical Technologies Llc | Stent having less invasive ends and improved radial force |
EP2413839B1 (en) * | 2009-04-02 | 2014-05-07 | Cook Medical Technologies LLC | System and method for maintaining patency of a stent using a magnet |
US9757263B2 (en) | 2009-11-18 | 2017-09-12 | Cook Medical Technologies Llc | Stent graft and introducer assembly |
US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US8398916B2 (en) | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
WO2011123203A1 (en) * | 2010-03-29 | 2011-10-06 | Boston Scientific Scimed, Inc. | Flexible stent design |
WO2011132803A1 (en) * | 2010-04-20 | 2011-10-27 | 주식회사 엠아이텍 | Stent for expanding blood vessels, with improved structure |
US11298251B2 (en) | 2010-11-17 | 2022-04-12 | Abbott Cardiovascular Systems, Inc. | Radiopaque intraluminal stents comprising cobalt-based alloys with primarily single-phase supersaturated tungsten content |
US9566147B2 (en) | 2010-11-17 | 2017-02-14 | Abbott Cardiovascular Systems, Inc. | Radiopaque intraluminal stents comprising cobalt-based alloys containing one or more platinum group metals, refractory metals, or combinations thereof |
EP2658484A1 (en) | 2010-12-30 | 2013-11-06 | Boston Scientific Scimed, Inc. | Multi stage opening stent designs |
WO2012119037A1 (en) | 2011-03-03 | 2012-09-07 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
CA2823535A1 (en) * | 2011-03-03 | 2012-09-07 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
US9724494B2 (en) | 2011-06-29 | 2017-08-08 | Abbott Cardiovascular Systems, Inc. | Guide wire device including a solderable linear elastic nickel-titanium distal end section and methods of preparation therefor |
US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
US9233015B2 (en) | 2012-06-15 | 2016-01-12 | Trivascular, Inc. | Endovascular delivery system with an improved radiopaque marker scheme |
CA2887879A1 (en) * | 2012-10-25 | 2014-05-01 | Beatrice Vial | Radiopaque marker for bioresorbable stents |
US9055999B2 (en) * | 2013-01-17 | 2015-06-16 | Medtronic Vascular, Inc. | Radiopaque markers for visualizing an edge of an endovascular graft |
US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
WO2015199816A1 (en) | 2014-06-24 | 2015-12-30 | Icon Medical Corp. | Improved metal alloys for medical devices |
US10206796B2 (en) | 2014-08-27 | 2019-02-19 | DePuy Synthes Products, Inc. | Multi-strand implant with enhanced radiopacity |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
US11766506B2 (en) | 2016-03-04 | 2023-09-26 | Mirus Llc | Stent device for spinal fusion |
US10076428B2 (en) | 2016-08-25 | 2018-09-18 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
US10292851B2 (en) | 2016-09-30 | 2019-05-21 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
CN109966034B (en) * | 2017-12-27 | 2021-08-17 | 先健科技(深圳)有限公司 | Covered stent |
AU2019204522A1 (en) | 2018-07-30 | 2020-02-13 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
US10456280B1 (en) | 2018-08-06 | 2019-10-29 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
US10278848B1 (en) | 2018-08-06 | 2019-05-07 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
DE102018222595A1 (en) * | 2018-12-20 | 2020-06-25 | Siemens Healthcare Gmbh | Process for image processing of an image data set of a patient, medical imaging device, computer program and electronically readable data carrier |
US11039944B2 (en) | 2018-12-27 | 2021-06-22 | DePuy Synthes Products, Inc. | Braided stent system with one or more expansion rings |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0801933A1 (en) * | 1996-04-10 | 1997-10-22 | Variomed AG | Stent for intraluminal placement in hollow organs |
WO1999025273A1 (en) * | 1997-11-14 | 1999-05-27 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
US6293966B1 (en) * | 1997-05-06 | 2001-09-25 | Cook Incorporated | Surgical stent featuring radiopaque markers |
US6299635B1 (en) * | 1997-09-29 | 2001-10-09 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US20010029397A1 (en) * | 1998-03-27 | 2001-10-11 | Thompson Paul J. | Stent |
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69528216T2 (en) * | 1994-06-17 | 2003-04-17 | Terumo Corp | Process for the production of a permanent stent |
US6331188B1 (en) * | 1994-08-31 | 2001-12-18 | Gore Enterprise Holdings, Inc. | Exterior supported self-expanding stent-graft |
US5643580A (en) * | 1994-10-17 | 1997-07-01 | Surface Genesis, Inc. | Biocompatible coating, medical device using the same and methods |
US5755770A (en) * | 1995-01-31 | 1998-05-26 | Boston Scientific Corporatiion | Endovascular aortic graft |
US7204848B1 (en) * | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
IL117472A0 (en) * | 1996-03-13 | 1996-07-23 | Instent Israel Ltd | Radiopaque stent markers |
US5922020A (en) * | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
US5824046A (en) * | 1996-09-27 | 1998-10-20 | Scimed Life Systems, Inc. | Covered stent |
US5858556A (en) * | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US6272370B1 (en) * | 1998-08-07 | 2001-08-07 | The Regents Of University Of Minnesota | MR-visible medical device for neurological interventions using nonlinear magnetic stereotaxis and a method imaging |
US6340367B1 (en) * | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
JP4292710B2 (en) * | 1997-09-24 | 2009-07-08 | エム イー ディ インスチィチュート インク | Radially expandable stent |
DE19746735C2 (en) * | 1997-10-13 | 2003-11-06 | Simag Gmbh Systeme Und Instr F | NMR imaging method for the display, position determination or functional control of a device inserted into an examination object and device for use in such a method |
AUPP083597A0 (en) * | 1997-12-10 | 1998-01-08 | William A Cook Australia Pty Ltd | Endoluminal aortic stents |
US6022374A (en) * | 1997-12-16 | 2000-02-08 | Cardiovasc, Inc. | Expandable stent having radiopaque marker and method |
US6656215B1 (en) * | 2000-11-16 | 2003-12-02 | Cordis Corporation | Stent graft having an improved means for attaching a stent to a graft |
US6524336B1 (en) * | 1998-04-09 | 2003-02-25 | Cook Incorporated | Endovascular graft |
US6361759B1 (en) * | 1998-05-26 | 2002-03-26 | Wisconsin Alumni Research Foundation | MR signal-emitting coatings |
US8092514B1 (en) | 1998-11-16 | 2012-01-10 | Boston Scientific Scimed, Inc. | Stretchable anti-buckling coiled-sheet stent |
US6340366B2 (en) * | 1998-12-08 | 2002-01-22 | Bandula Wijay | Stent with nested or overlapping rings |
US6361557B1 (en) * | 1999-02-05 | 2002-03-26 | Medtronic Ave, Inc. | Staplebutton radiopaque marker |
US6379381B1 (en) * | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6355058B1 (en) * | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
US6423090B1 (en) | 2000-02-11 | 2002-07-23 | Advanced Cardiovascular Systems, Inc. | Stent pattern with staged expansion |
US7828835B2 (en) * | 2000-03-01 | 2010-11-09 | Medinol Ltd. | Longitudinally flexible stent |
US6652579B1 (en) | 2000-06-22 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
US6623518B2 (en) * | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
US20040111147A1 (en) * | 2002-12-03 | 2004-06-10 | Rabkin Dmitry J. | Temporary, repositionable or retrievable intraluminal devices |
US20030176914A1 (en) * | 2003-01-21 | 2003-09-18 | Rabkin Dmitry J. | Multi-segment modular stent and methods for manufacturing stents |
US7195648B2 (en) * | 2002-05-16 | 2007-03-27 | Cordis Neurovascular, Inc. | Intravascular stent device |
US20030225448A1 (en) | 2002-05-28 | 2003-12-04 | Scimed Life Systems, Inc. | Polar radiopaque marker for stent |
US7223283B2 (en) * | 2002-10-09 | 2007-05-29 | Boston Scientific Scimed, Inc. | Stent with improved flexibility |
US20040088039A1 (en) | 2002-11-01 | 2004-05-06 | Lee Nathan T. | Method of securing radiopaque markers to an implant |
US20050060025A1 (en) | 2003-09-12 | 2005-03-17 | Mackiewicz David A. | Radiopaque markers for medical devices |
US7243408B2 (en) | 2004-02-09 | 2007-07-17 | Boston Scientific Scimed, Inc. | Process method for attaching radio opaque markers to shape memory stent |
-
2002
- 2002-10-09 US US10/269,112 patent/US7331986B2/en not_active Expired - Lifetime
-
2003
- 2003-08-27 AT AT03752146T patent/ATE474531T1/en not_active IP Right Cessation
- 2003-08-27 DE DE60333481T patent/DE60333481D1/en not_active Expired - Lifetime
- 2003-08-27 WO PCT/US2003/028220 patent/WO2004032801A1/en not_active Application Discontinuation
- 2003-08-27 EP EP03752146A patent/EP1572028B1/en not_active Expired - Lifetime
- 2003-08-27 AU AU2003270453A patent/AU2003270453A1/en not_active Abandoned
-
2007
- 2007-05-23 US US11/752,627 patent/US8038705B2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6334871B1 (en) * | 1996-03-13 | 2002-01-01 | Medtronic, Inc. | Radiopaque stent markers |
EP0801933A1 (en) * | 1996-04-10 | 1997-10-22 | Variomed AG | Stent for intraluminal placement in hollow organs |
US6293966B1 (en) * | 1997-05-06 | 2001-09-25 | Cook Incorporated | Surgical stent featuring radiopaque markers |
US6299635B1 (en) * | 1997-09-29 | 2001-10-09 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
WO1999025273A1 (en) * | 1997-11-14 | 1999-05-27 | Transvascular, Inc. | Devices for forming and/or maintaining connections between adjacent anatomical conduits |
US20010029397A1 (en) * | 1998-03-27 | 2001-10-11 | Thompson Paul J. | Stent |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1452151A2 (en) * | 2003-02-25 | 2004-09-01 | Cordis Corporation | Stent with nested fingers for enhaced vessel coverage |
EP1452151A3 (en) * | 2003-02-25 | 2006-07-19 | Cordis Corporation | Stent with nested fingers for enhaced vessel coverage |
US7918884B2 (en) | 2003-02-25 | 2011-04-05 | Cordis Corporation | Stent for treatment of bifurcated lesions |
US7942920B2 (en) | 2003-02-25 | 2011-05-17 | Cordis Corporation | Stent with nested fingers for enhanced vessel coverage |
WO2005030286A1 (en) * | 2003-09-24 | 2005-04-07 | Boston Scientific Limited | Medical device with markers for magnetic resonance visibility |
EP1570807A2 (en) * | 2003-10-29 | 2005-09-07 | Medtronic Vascular, Inc. | Intralumenal stent device for use in body lumens of various diameters |
Also Published As
Publication number | Publication date |
---|---|
DE60333481D1 (en) | 2010-09-02 |
US20070219624A1 (en) | 2007-09-20 |
US8038705B2 (en) | 2011-10-18 |
EP1572028B1 (en) | 2010-07-21 |
US20040073291A1 (en) | 2004-04-15 |
ATE474531T1 (en) | 2010-08-15 |
EP1572028A1 (en) | 2005-09-14 |
AU2003270453A1 (en) | 2004-05-04 |
US7331986B2 (en) | 2008-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7331986B2 (en) | Intraluminal medical device having improved visibility | |
US7291167B2 (en) | Stent having radiopaque markers and method of fabricating the same | |
US6402777B1 (en) | Radiopaque stent markers | |
US7226475B2 (en) | Stent with variable properties | |
US7309352B2 (en) | Expandable coil stent | |
US6464723B1 (en) | Radiopaque stents | |
JP5020461B2 (en) | Improved radiopaque intraluminal medical device | |
EP1488763B1 (en) | Stent with attached sleeve marker | |
US6585757B1 (en) | Endovascular stent with radiopaque spine | |
JP5016708B2 (en) | Expandable endoluminal prosthesis | |
EP1492471B1 (en) | Hybrid stent | |
US6331189B1 (en) | Flexible medical stent | |
US6863685B2 (en) | Radiopacity intraluminal medical device | |
JP4429623B2 (en) | Low profile radiopaque endovascular medical device | |
EP0945107A2 (en) | Helical stent | |
EP1874221B1 (en) | Endoprosthesis | |
AU2010210022B1 (en) | Stent graft having a marker and a reinforcing and marker ring | |
JP2004283591A (en) | Anvil bridge stent design | |
JP4667758B2 (en) | Split bridge stent design | |
CN115969592A (en) | Vascular implant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003752146 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003752146 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |